Skip to main content
Premium Trial:

Request an Annual Quote

Michael Callaghan, Phiet Bui

Premium
Michael Callaghan resigned from Vermillion’s board on June 11, the company revealed in a document filed with the US Securities and Exchange Commission last week.
 
Callaghan left for personal reason and “not the result of any disagreement with the company on any matter relating to the company’s operations, policies, or practices,” Vermillion said in its document. Callaghan served on the audit and compensation committees of the board.
 

 
Miraculins said this week that company co-founder Phiet Bui is stepping down from its board and as its CSO as part of the firm’s make-over.
 
The company is moving away from proteomics research and discovery to diagnostic assay development and commercialization [See related story, this issue]. Before becoming CSO of Miraculins, Bui was president of the company.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.